Airna is a biotechnology company focused on the discovery and development of RNA editing therapeutics for rare and common diseases.

Airna

AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA editing therapeutics driven by its powerful and flexible RNA editing platform, RESTORE+.

AIRNA

We're #hiring a new Finance and Human Resources Manager- Germany in Tübingen, Baden-Württemberg. Apply today or share this post with your network.

We at AIRNA are excited about the impact that RNA editing can have for patients. 
This review in Nature's Drug Discovery journal highlights the potential of RNA editing as companies are moving into the clinic. Thorsten Stafforst, AIRNA co-founder whose lab pioneered this field, highlighted this potential by saying, "There are billions of things you can imagine doing.” 
AATD is just the beginning as RNA editing can unlock a wide spectrum of genetically-validated, difficult to drug targets. Our CEO Kris Elverum believes, “We may be able to introduce gain-of-function variants into people in a safe, temporary and dose-dependent manner.”


https://lnkd.in/gD6_heX4

AIRNA is growing! We are excited and can't wait to bring new team members on board! #hiring #rna #biotech

We're #hiring a new Human Resources Manager- Germany in Tübingen, Baden-Württemberg. Apply today or share this post with your network.

We're #hiring a new Senior Research Associate in Cambridge, Massachusetts. Apply today or share this post with your network.

We're #hiring a new Director, Computational Biology and Bioinformatics in Cambridge, Massachusetts. Apply today or share this post with your network.

COM:AIRNA

Airna

Analysis Not Available